MediWound (MDWD) Cash from Operations Growth (3y) (2016 - 2025)
MediWound (MDWD) Cash from Operations Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 34.32% |
| 10 | MediWound | 167.52 Mn | 162.72 Mn | 278,000.00 | -81.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -81.93% |
| Sep 30, 2025 | 10.82% |
| Jun 30, 2025 | -3.09% |
| Mar 31, 2025 | -0.37% |
| Dec 31, 2024 | 9.86% |
| Sep 30, 2024 | -10.05% |
| Jun 30, 2024 | -54.36% |
| Mar 31, 2024 | -4.27% |
| Dec 31, 2023 | 7.62% |
| Sep 30, 2023 | -72.42% |
| Jun 30, 2023 | -23.10% |
| Mar 31, 2023 | 33.17% |
| Dec 31, 2022 | 32.51% |
| Sep 30, 2022 | 1.55% |
| Jun 30, 2022 | -32.08% |
| Mar 31, 2022 | -30.10% |
| Dec 31, 2021 | -3.65% |
| Sep 30, 2021 | -28.47% |
| Jun 30, 2021 | 44.26% |
| Mar 31, 2021 | -9.09% |